⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29256289 | 0.85 | TSHR (0.36) | — | |
| SCHEMBL28169407 | 0.77 | TSHR (0.43) | — | |
| SCHEMBL2505557 | 0.76 | — | — | |
| SCHEMBL6960289 | 0.76 | — | — | |
| SCHEMBL26928 | 0.75 | — | — | |
| SCHEMBL28353573 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL11311337 | 0.74 | — | — | |
| SCHEMBL11059102 | 0.72 | — | — | |
| SCHEMBL6960246 | 0.72 | — | — | |
| SCHEMBL8892122 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105585612-B | Octapeptide modified dexamethasone, preparation, nanostructure and application | 北京益生康华医药技术有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-105585611-B | Octapeptide modified dexamethasone, preparation, nanostructure and application thereof | 北京益生康华医药技术有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-105504013-B | Octapeptide modified dexamethasone, preparation, nanostructure and application thereof | 北京益生康华医药技术有限公司 | 2020-05-01 | — | — | CN | claimed |
| US-7759468-B1 | modifying a 6-[N-(6-aminohexyl)-N-ethylamino]-2,3-dihydro-phthalazine-1,4-dione marker to include an amino-terminal carboxymethoxyacetyl tether molecule, and covalently binding the tether molecule to a bacteriophage-derived peptide; suitable for a rapid assay for a bacteria in a complex mixture | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-07-20 | — | — | US | claimed |
| EP-1945611-B1 | N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES | NOVARTIS AG (CH) | 2010-01-06 | — | — | EP | claimed |
| US-20090227538-A1 | N-(Hetero)Aryl Indole Derivatives as Pesticides | NOVARTIS AG (CH) | 2009-09-10 | — | — | US | claimed |
| EP-1945611-A1 | N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES | Novartis Pharma AG (CH) | 2008-07-23 | — | — | EP | claimed |
| WO-2007051619-A1 | N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES | NOVARTIS AG (CH) | 2007-05-10 | — | — | WO | claimed |
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2005-01-20 | — | — | US | claimed |
| WO-2004089357-A2 | ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-10-21 | — | — | WO | claimed |
| US-20040097436-A1 | Triterpenes having antibacterial activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2004-05-20 | — | — | US | claimed |
| EP-1140802-B1 | SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES | BOEHRINGER INGELHEIM PHARMA (DE) | 2004-03-17 | — | — | EP | claimed |
| US-6689767-B2 | TRITERPENE BACTERICIDES | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2004-02-10 | — | — | US | claimed |
| EP-1322661-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2003-07-02 | — | — | EP | claimed |
| US-6479524-B1 | TO PROLONG THE THROMBIN TIME | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-11-12 | — | — | US | claimed |
| US-20020128210-A1 | Triterpenes having human antifungal and antiyeast activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-09-12 | — | — | US | claimed |
| US-20020119935-A1 | Triterpenes having antibacterial activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-08-29 | — | — | US | claimed |
| WO-2002026762-A1 | TRITERPENES HAVING ANTIBACTERIAL ACTIVITY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | claimed |
| WO-2002026761-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | claimed |
| EP-4210729-A2 | INSULIN RECEPTOR PARTIAL AGONISTS | Merck Sharp & Dohme LLC (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-4204442-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | Merck Sharp & Dohme LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| WO-2022055877-A2 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2022-03-17 | — | — | WO | disclosed |
| CN-105585612-B | Octapeptide modified dexamethasone, preparation, nanostructure and application | 北京益生康华医药技术有限公司 | 2020-05-05 | — | — | CN | disclosed |
| CN-105585611-B | Octapeptide modified dexamethasone, preparation, nanostructure and application thereof | 北京益生康华医药技术有限公司 | 2020-05-05 | — | — | CN | disclosed |
| CN-105504013-B | Octapeptide modified dexamethasone, preparation, nanostructure and application thereof | 北京益生康华医药技术有限公司 | 2020-05-01 | — | — | CN | disclosed |
| US-20140357838-A1 | N-Terminally Modified Insulin Derivatives | NOVO NORDISK A/S (DK) | 2014-12-04 | — | — | US | disclosed |
| EP-2794648-A1 | N-TERMINALLY MODIFIED INSULIN DERIVATIVES | Novo Nordisk A/S (DK) | 2014-10-29 | — | — | EP | disclosed |
| US-20140315797-A1 | Novel N-Terminally Modified Insulin Derivatives | NOVO NORDISK A/S (DK) | 2014-10-23 | — | — | US | disclosed |
| EP-2627670-A2 | NOVEL N-TERMINALLY MODIFIED INSULIN DERIVATIVES | Novo Nordisk A/S (DK) | 2013-08-21 | — | — | EP | disclosed |
| WO-2013093009-A1 | N -TERMINALLY MODIFIED INSULIN DERIVATIVES | NOVO NORDISK A/S (DK) | 2013-06-27 | — | — | WO | disclosed |
| WO-2012049307-A2 | NOVEL N-TERMINALLY MODIFIED INSULIN DERIVATIVES | NOVO NORDISK A/S (DK) | 2012-04-19 | — | — | WO | disclosed |
| US-20100292188-A1 | Compounds Comprising A Cyclobutoxy Group | UCB PHARMA S.A. (BE) | 2010-11-18 | — | — | US | disclosed |
| EP-2238144-A1 | COMPOUNDS COMPRISING A CYCLOBUTOXY GROUP | UCB Pharma, S.A. (BE) | 2010-10-13 | — | — | EP | disclosed |
| EP-1945611-B1 | N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES | NOVARTIS AG (CH) | 2010-01-06 | — | — | EP | disclosed |
| US-20090227538-A1 | N-(Hetero)Aryl Indole Derivatives as Pesticides | NOVARTIS AG (CH) | 2009-09-10 | — | — | US | disclosed |
| WO-2009092764-A1 | COMPOUNDS COMPRISING A CYCLOBUTOXY GROUP | UCB PHARMA, S.A. (BE) | 2009-07-30 | — | — | WO | disclosed |
| EP-1945611-A1 | N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES | Novartis Pharma AG (CH) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007051619-A1 | N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES | NOVARTIS AG (CH) | 2007-05-10 | — | — | WO | disclosed |
| US-20060003948-A1 | Compositions that include a triterpene and a carrier | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2006-01-05 | — | — | US | disclosed |
| WO-2005077377-A1 | COMPOSITIONS THAT INCLUDE A TRITERPENE AND A CARRIER | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-08-25 | — | — | WO | disclosed |
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2005-01-20 | — | — | US | disclosed |
| WO-2004089357-A2 | ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-10-21 | — | — | WO | disclosed |
| US-20040097436-A1 | Triterpenes having antibacterial activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2004-05-20 | — | — | US | disclosed |
| EP-1140802-B1 | SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES | BOEHRINGER INGELHEIM PHARMA (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-6689767-B2 | TRITERPENE BACTERICIDES | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2004-02-10 | — | — | US | disclosed |
| US-6642217-B2 | Treating a fungal or yeast infection such as with betulin, allobetulin, and lupeol | NATURTEK, LLC | 2003-11-04 | — | — | US | disclosed |
| EP-1322661-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2003-07-02 | — | — | EP | disclosed |
| US-6479524-B1 | TO PROLONG THE THROMBIN TIME | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-11-12 | — | — | US | disclosed |
| US-20020128210-A1 | Triterpenes having human antifungal and antiyeast activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-09-12 | — | — | US | disclosed |
| US-20020119935-A1 | Triterpenes having antibacterial activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-08-29 | — | — | US | disclosed |
| WO-2002026762-A1 | TRITERPENES HAVING ANTIBACTERIAL ACTIVITY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | disclosed |
| WO-2002026761-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | disclosed |
| US-5643878-A | TREATMENT OF RETROVIRAL DISEASES LIKE AIDS | CIBA-GEIGY CORPORATION (US) | 1997-07-01 | — | — | US | disclosed |
| EP-0618222-A2 | Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid | CIBA-GEIGY AG (CH) | 1994-10-05 | — | — | EP | disclosed |
| EP-0618222-A2 | Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid | CIBA-GEIGY AG (CH) | 1994-10-05 | — | — | EP | disclosed |